Diaveridine
| Title | Journal |
|---|---|
| Insights into myalgic encephalomyelitis/chronic fatigue syndrome phenotypes through comprehensive metabolomics. | Scientific reports 20180101 |
| Target guided synthesis of 5-benzyl-2,4-diamonopyrimidines: their antimalarial activities and binding affinities to wild type and mutant dihydrofolate reductases from Plasmodium falciparum. | Journal of medicinal chemistry 20040115 |
| Mutagenic activity and mutational specificity of antiprotozoal drugs with and without nitrite treatment. | Environmental and molecular mutagenesis 20020101 |
| Adaptive neuro-fuzzy inference system: an instant and architecture-free predictor for improved QSAR studies. | Journal of medicinal chemistry 20010816 |
| In-vitro activity of lytic peptides alone and in combination with macrolides and inhibitors of dihydrofolate reductase against Pneumocystis carinii. | The Journal of antimicrobial chemotherapy 19981001 |
| Efficacy of 101 antimicrobials and other agents on the development of Cryptosporidium parvum in vitro. | Annals of tropical medicine and parasitology 19961201 |
| Fine structural specificity differences of trimethoprim allergenic determinants. | Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 19961001 |
| Treatment of experimental pneumocystosis: review of 7 years of experience and development of a new system for classifying antimicrobial drugs. | Antimicrobial agents and chemotherapy 19920901 |
| [Synthesis and antimycobacterial action of lipophilic substituted 2,4-diamino-5-benzylpyrimidines]. | Arzneimittel-Forschung 19881201 |
| 5-BENZYL-2,4-DIAMINOPYRIMIDINES AS ANTIBACTERIAL AGENTS. I. SYNTHESIS AND ANTIBACTERIAL ACTIVITY IN VITRO. | Journal of medicinal and pharmaceutical chemistry 19621101 |